Cannara Biotech, Inc. (LOVFF)
1.22
0.00 (0.00%)
USD |
OTCM |
Dec 24, 16:00
Cannara Biotech Market Cap: 115.88M for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 104.38M |
| Aurinia Pharmaceuticals, Inc. | 2.146B |
| Edesa Biotech, Inc. | 9.139M |
| Lexaria Bioscience Corp. | 13.94M |
| Xenon Pharmaceuticals, Inc. | 3.478B |
Market Cap Related Metrics
| PE Ratio | 12.01 |
| PS Ratio | 1.459 |
| PEG Ratio | 0.1229 |
| Price to Book Value | 1.556 |
| Price to Free Cash Flow | 15.15 |
| Price | 1.22 |
| Earnings Yield | 8.33% |
| PEGY Ratio | 0.1229 |